Previous close | 12.50 |
Open | 12.50 |
Bid | 0.00 |
Ask | 4.80 |
Strike | 380.00 |
Expiry date | 2023-03-17 |
Day's range | 12.50 - 12.50 |
Contract range | N/A |
Volume | |
Open interest | 11 |
VAREX IMAGING (VREX) delivered earnings and revenue surprises of -27.27% and 0.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Sustained sales gains in terms of the Bio-Rads (BIO) process media, western blotting, Droplet Digital PCR and qPCR products are likely to drive Q4 revenues.
HERCULES, Calif., January 06, 2023--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the fourth quarter and full year 2022 on Thursday, February 16, 2023, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.